S2-E19.2 - Patient-Centric Themes At The 4th Global NASH Congress
Send us a text Jörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review holistic and patient-centric issues to be covered at the 4th Global NASH Congress. Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review patient-centric topics covered at the Congress. This conversation discusses the increasing imoportance of pheno...
17 Apr 202116min
S2-E19.1 - Non-Invasive Testing Themes at the 4th Global NASH Congress
Send us a text Jörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to review non-invasive testing themes to be covered at the 4th Global NASH Congress. Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review non-invasive testing topics covered at the Congress. This conversation discusses advances in technology and the need for...
17 Apr 202113min
S2-E19 - Previewing the 4th Global NASH congress
Send us a text Jörn Schattenberg and GenFit Global Diagnostics Leader Suneil Hosmane join the Surfers to survey the agenda for the 4th Global NASH Congress. The 4th Global NASH Congress has presentations of interest on a broad array of topics. Congress Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for this event. Along with Jörn Schattenberg, they review the topics of interest at the Congress and highlight some papers and topics that SurfingNA...
15 Apr 202147min
S2 E18.3 -- Stephen Harrison and Alina Allen discuss what her work portends for future trials.
Send us a text Roger Green conducts one-on-one interviews with Stephen Harrison and Alina Allen to explore specific issues regarding new issues and insights for clinical research and drug development resulting from the work of Dr. Allen and her colleagues. Stephen Harrison discusses the important contribution this paper makes to our knowledge about disease progression. He then suggests several types of studies and issues that are likely to progress from this research and closes by focusing o...
11 Apr 202120min
S2 E18.2 -- How Might We Treat Differently If We Knew Which Cirrhotic Patients Are Likely To Progress?
Send us a text The group focuses on the patient treatment implications of being able to identify the patients who are at risk of rapid progression, particularly among those with compensated cirrhosis. Louise Campbell and Alina Allen discuss the psychological and practical aspects of treating patients (particularly those with cirrhosis) who know they are risk of imminent disease progression, while Roger Green asks whether this kind of predictive power might drive Compassionate Use protocols ...
10 Apr 202123min
S2 E18.1 -- How Does MR Elastography Help Identify NASH PAtients Who Are Likely To Progress?
Send us a text Alina Allen shares the results of her recent Clinical Gastroenterology and Hepatology paper on predictive value of MR Elastography in determining likelihood of progress for NASH patients exhibiting F1 - F3 disease and separately, those living with cirrhosis. Using a longitudinal data base of over 800 patients spanning 12 years, Dr. Allen and her colleagues published analysis demonstrated that kPa readings based on MR Elastography produced highly significant results predi...
10 Apr 202115min
S2-E18 - Magnetic Resonance Elastography Predicts Prognosis for NASH patients
Send us a text Alina Allen of the Mayo Clinic joins the Surfers to discuss her recent publication demonstrating that kPa scores from MR Elastography can predict the course of disease for non-cirrhotic and cirrhotic patients and consider its implications for clinical trials and every day patient treatment. This episode has an unusual format. First, Alina Allen discusses her study and its implications with Louise Campbell and Roger Green. Next, Roger interviews Stephen Harrison on what he consi...
8 Apr 20211h 9min
S2-E17.3 -- The value of ultrasound and the goals of patient screenin
Send us a text Ian Rowe presents more findings from his work in Leeds, revealing paradoxes and complexity in the patient screening process. This conversations starts by questioning the incremental value of ultrasound in the diagnostic process and proceeds to consider the goals of screening and two specific challenges. This conversation focuses on how to improve diagnostic accuracy and speed, starting with the question of how often ultrasound contributes to a more robust diagnosis than a pro...
4 Apr 202114min
